Primary cutaneous anaplastic large cell lymphoma: a clinicopathologic analysis of 8 cases.
- Author:
Ting-ting WANG
1
;
Lin WANG
;
Zhi-rong TANG
;
Ji-rong CHENG
;
Wei LI
;
Feng-yuan LI
;
Wei-ya WANG
;
Gan-di LI
Author Information
- Publication Type:Journal Article
- MeSH: Adult; Aged; CD5 Antigens; metabolism; Child; Combined Modality Therapy; Female; Follow-Up Studies; Humans; Immunophenotyping; In Situ Hybridization; Ki-1 Antigen; metabolism; Leukocyte Common Antigens; metabolism; Lymphoma, Primary Cutaneous Anaplastic Large Cell; immunology; metabolism; pathology; therapy; Male; Middle Aged; Prognosis; RNA, Viral; metabolism; Skin Neoplasms; immunology; metabolism; pathology; therapy; Young Adult
- From: Chinese Journal of Pathology 2009;38(11):749-753
- CountryChina
- Language:Chinese
-
Abstract:
OBJECTIVETo study the clinicopathologic features, immunophenotype and prognosis of primary cutaneous anaplastic large cell lymphoma (C-ALCL).
METHODSEight cases of C-ALCL were enrolled into the study. The clinicopathologic features, immunohistochemical findings and results of in-situ hybridization for EBER 1/2 were analyzed.
RESULTSThree of the 8 patients were males and 5 were females. The median age was 49.5 years. C-ALCL often presented with solitary skin nodule, without systemic symptoms. Histologically, the lymphoma cells infiltrated the dermis and subcutis in a sheet-like pattern. They were of large size and showed conspicuous nuclear atypia. Immunohistochemical study showed that more than 75% of the lymphoma cells were positive for CD30. All cases expressed one to three T cell markers (CD3, CD5 or CD45RO) and cytotoxic granule-associated antigens (TIA-1, granzyme B or perforin). The staining for leukocyte common antigen was positive in all cases, while the expression of CD5, CD8, ALK-1 and epithelial membrane antigen was noted in 5, 1, 1 and 3 cases, respectively. The staining for CD15, CD20, CK and HMB45 was negative. In-situ hybridization for EBER 1/2 was also negative in all the cases studied. Follow-up information was available in 6 patients. Five of them were still alive and 1 died of unclear cause.
CONCLUSIONSC-ALCL has distinctive clinicopathologic and immunophenotypic features. It is not Epstein-Barr virus-related and often carries a favorable prognosis.